Prevention of Shingles: Better Protection and Better Value With Recombinant Vaccine

In their article, Prosser and colleagues evaluate the cost-effectiveness of recombinant zoster vaccine compared with zoster vaccine live and no zoster vaccination. The editorial discusses the findings in light of current immunization recommendations.

http://bit.ly/2Nkjy0x